nodes	percent_of_prediction	percent_of_DWPC	metapath
Propylthiouracil—DIO1—lung—systemic scleroderma	0.037	0.202	CbGeAlD
Propylthiouracil—MPO—artery—systemic scleroderma	0.0242	0.132	CbGeAlD
Propylthiouracil—MPO—endothelium—systemic scleroderma	0.0204	0.111	CbGeAlD
Propylthiouracil—TPO—digestive system—systemic scleroderma	0.02	0.109	CbGeAlD
Propylthiouracil—TPO—tendon—systemic scleroderma	0.019	0.104	CbGeAlD
Propylthiouracil—MPO—blood vessel—systemic scleroderma	0.0188	0.103	CbGeAlD
Propylthiouracil—DBH—digestive system—systemic scleroderma	0.013	0.071	CbGeAlD
Propylthiouracil—MPO—connective tissue—systemic scleroderma	0.00965	0.0526	CbGeAlD
Propylthiouracil—MPO—skin of body—systemic scleroderma	0.00871	0.0475	CbGeAlD
Propylthiouracil—Neuritis—Leflunomide—systemic scleroderma	0.00781	0.00991	CcSEcCtD
Propylthiouracil—Skin ulcer—Leflunomide—systemic scleroderma	0.00749	0.00951	CcSEcCtD
Propylthiouracil—Liver injury—Azathioprine—systemic scleroderma	0.00733	0.00931	CcSEcCtD
Propylthiouracil—Vasculitis—Captopril—systemic scleroderma	0.00724	0.0092	CcSEcCtD
Propylthiouracil—Skin ulcer—Mycophenolic acid—systemic scleroderma	0.00714	0.00907	CcSEcCtD
Propylthiouracil—MPO—digestive system—systemic scleroderma	0.00697	0.038	CbGeAlD
Propylthiouracil—Liver injury—Leflunomide—systemic scleroderma	0.00693	0.0088	CcSEcCtD
Propylthiouracil—Liver injury—Mycophenolic acid—systemic scleroderma	0.00661	0.00839	CcSEcCtD
Propylthiouracil—Vasculitis—Azathioprine—systemic scleroderma	0.00632	0.00803	CcSEcCtD
Propylthiouracil—Interstitial lung disease—Mycophenolate mofetil—systemic scleroderma	0.0062	0.00787	CcSEcCtD
Propylthiouracil—Lymphadenopathy—Captopril—systemic scleroderma	0.00602	0.00764	CcSEcCtD
Propylthiouracil—Vasculitis—Leflunomide—systemic scleroderma	0.00597	0.00758	CcSEcCtD
Propylthiouracil—MPO—lung—systemic scleroderma	0.00582	0.0317	CbGeAlD
Propylthiouracil—Aplastic anaemia—Azathioprine—systemic scleroderma	0.00579	0.00736	CcSEcCtD
Propylthiouracil—Skin ulcer—Mycophenolate mofetil—systemic scleroderma	0.00564	0.00716	CcSEcCtD
Propylthiouracil—Renal failure acute—Captopril—systemic scleroderma	0.00556	0.00706	CcSEcCtD
Propylthiouracil—Dermatitis exfoliative—Captopril—systemic scleroderma	0.00544	0.00691	CcSEcCtD
Propylthiouracil—Ageusia—Mycophenolate mofetil—systemic scleroderma	0.00542	0.00688	CcSEcCtD
Propylthiouracil—Lung infiltration—Methotrexate—systemic scleroderma	0.0053	0.00673	CcSEcCtD
Propylthiouracil—Drowsiness—Pentoxifylline—systemic scleroderma	0.00522	0.00663	CcSEcCtD
Propylthiouracil—Liver injury—Mycophenolate mofetil—systemic scleroderma	0.00521	0.00662	CcSEcCtD
Propylthiouracil—Interstitial pneumonia—Methotrexate—systemic scleroderma	0.00514	0.00653	CcSEcCtD
Propylthiouracil—Vasculitis—Lisinopril—systemic scleroderma	0.00513	0.00652	CcSEcCtD
Propylthiouracil—Jaundice—Pentoxifylline—systemic scleroderma	0.00509	0.00646	CcSEcCtD
Propylthiouracil—Leukocytoclastic vasculitis—Methotrexate—systemic scleroderma	0.00507	0.00644	CcSEcCtD
Propylthiouracil—Hepatic failure—Azathioprine—systemic scleroderma	0.00498	0.00633	CcSEcCtD
Propylthiouracil—Lymphadenopathy—Leflunomide—systemic scleroderma	0.00496	0.0063	CcSEcCtD
Propylthiouracil—Lymphadenopathy—Mycophenolic acid—systemic scleroderma	0.00473	0.00601	CcSEcCtD
Propylthiouracil—Haemoglobin—Pentoxifylline—systemic scleroderma	0.00471	0.00598	CcSEcCtD
Propylthiouracil—Hepatic failure—Leflunomide—systemic scleroderma	0.00471	0.00598	CcSEcCtD
Propylthiouracil—Haemorrhage—Pentoxifylline—systemic scleroderma	0.00469	0.00595	CcSEcCtD
Propylthiouracil—Hepatitis—Pentoxifylline—systemic scleroderma	0.00469	0.00595	CcSEcCtD
Propylthiouracil—TPO—Hematopoietic Stem Cell Differentiation—CSF1—systemic scleroderma	0.00452	0.156	CbGpPWpGaD
Propylthiouracil—Renal failure acute—Mycophenolic acid—systemic scleroderma	0.00437	0.00555	CcSEcCtD
Propylthiouracil—Aplastic anaemia—Mycophenolate mofetil—systemic scleroderma	0.00412	0.00523	CcSEcCtD
Propylthiouracil—Hepatic failure—Lisinopril—systemic scleroderma	0.00404	0.00514	CcSEcCtD
Propylthiouracil—Dysgeusia—Pentoxifylline—systemic scleroderma	0.00399	0.00507	CcSEcCtD
Propylthiouracil—Neuritis—Prednisone—systemic scleroderma	0.00398	0.00506	CcSEcCtD
Propylthiouracil—Renal failure acute—Lisinopril—systemic scleroderma	0.00394	0.005	CcSEcCtD
Propylthiouracil—TPO—Differentiation Pathway—CSF1—systemic scleroderma	0.00391	0.135	CbGpPWpGaD
Propylthiouracil—Jaundice—Captopril—systemic scleroderma	0.00386	0.0049	CcSEcCtD
Propylthiouracil—Lymphadenopathy—Mycophenolate mofetil—systemic scleroderma	0.00373	0.00474	CcSEcCtD
Propylthiouracil—Agranulocytosis—Captopril—systemic scleroderma	0.00369	0.00469	CcSEcCtD
Propylthiouracil—Leukopenia—Pentoxifylline—systemic scleroderma	0.00365	0.00464	CcSEcCtD
Propylthiouracil—Hepatitis—Captopril—systemic scleroderma	0.00355	0.00451	CcSEcCtD
Propylthiouracil—Hepatic failure—Mycophenolate mofetil—systemic scleroderma	0.00354	0.0045	CcSEcCtD
Propylthiouracil—Interstitial lung disease—Methotrexate—systemic scleroderma	0.00351	0.00446	CcSEcCtD
Propylthiouracil—Myalgia—Pentoxifylline—systemic scleroderma	0.00347	0.00441	CcSEcCtD
Propylthiouracil—Renal failure acute—Mycophenolate mofetil—systemic scleroderma	0.00345	0.00438	CcSEcCtD
Propylthiouracil—Oedema—Pentoxifylline—systemic scleroderma	0.00333	0.00423	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Pentoxifylline—systemic scleroderma	0.00326	0.00414	CcSEcCtD
Propylthiouracil—Agranulocytosis—Azathioprine—systemic scleroderma	0.00322	0.00409	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Leflunomide—systemic scleroderma	0.0032	0.00406	CcSEcCtD
Propylthiouracil—Skin ulcer—Methotrexate—systemic scleroderma	0.00319	0.00405	CcSEcCtD
Propylthiouracil—Jaundice—Leflunomide—systemic scleroderma	0.00318	0.00404	CcSEcCtD
Propylthiouracil—Alopecia—Captopril—systemic scleroderma	0.00314	0.00398	CcSEcCtD
Propylthiouracil—Haemoglobin—Azathioprine—systemic scleroderma	0.00311	0.00396	CcSEcCtD
Propylthiouracil—Haemorrhage—Azathioprine—systemic scleroderma	0.0031	0.00394	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Mycophenolic acid—systemic scleroderma	0.00305	0.00387	CcSEcCtD
Propylthiouracil—Vasculitis—Prednisone—systemic scleroderma	0.00305	0.00387	CcSEcCtD
Propylthiouracil—Agranulocytosis—Leflunomide—systemic scleroderma	0.00304	0.00386	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Pentoxifylline—systemic scleroderma	0.00303	0.00385	CcSEcCtD
Propylthiouracil—Jaundice—Mycophenolic acid—systemic scleroderma	0.00303	0.00385	CcSEcCtD
Propylthiouracil—Dysgeusia—Captopril—systemic scleroderma	0.00303	0.00384	CcSEcCtD
Propylthiouracil—Myalgia—Mometasone—systemic scleroderma	0.003	0.00381	CcSEcCtD
Propylthiouracil—Arthralgia—Mometasone—systemic scleroderma	0.003	0.00381	CcSEcCtD
Propylthiouracil—Somnolence—Pentoxifylline—systemic scleroderma	0.00296	0.00376	CcSEcCtD
Propylthiouracil—Haemoglobin—Leflunomide—systemic scleroderma	0.00294	0.00374	CcSEcCtD
Propylthiouracil—Dyspepsia—Pentoxifylline—systemic scleroderma	0.00293	0.00372	CcSEcCtD
Propylthiouracil—Hepatitis—Leflunomide—systemic scleroderma	0.00293	0.00372	CcSEcCtD
Propylthiouracil—Haemorrhage—Leflunomide—systemic scleroderma	0.00293	0.00372	CcSEcCtD
Propylthiouracil—Agranulocytosis—Mycophenolic acid—systemic scleroderma	0.0029	0.00369	CcSEcCtD
Propylthiouracil—Haemoglobin—Mycophenolic acid—systemic scleroderma	0.00281	0.00356	CcSEcCtD
Propylthiouracil—Hepatitis—Mycophenolic acid—systemic scleroderma	0.00279	0.00355	CcSEcCtD
Propylthiouracil—Haemorrhage—Mycophenolic acid—systemic scleroderma	0.00279	0.00355	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Lisinopril—systemic scleroderma	0.00275	0.00349	CcSEcCtD
Propylthiouracil—Alopecia—Azathioprine—systemic scleroderma	0.00274	0.00348	CcSEcCtD
Propylthiouracil—Jaundice—Lisinopril—systemic scleroderma	0.00273	0.00347	CcSEcCtD
Propylthiouracil—Urticaria—Pentoxifylline—systemic scleroderma	0.00264	0.00336	CcSEcCtD
Propylthiouracil—Myalgia—Captopril—systemic scleroderma	0.00263	0.00334	CcSEcCtD
Propylthiouracil—Arthralgia—Captopril—systemic scleroderma	0.00263	0.00334	CcSEcCtD
Propylthiouracil—Body temperature increased—Pentoxifylline—systemic scleroderma	0.00263	0.00334	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Mometasone—systemic scleroderma	0.00262	0.00332	CcSEcCtD
Propylthiouracil—Agranulocytosis—Lisinopril—systemic scleroderma	0.00261	0.00332	CcSEcCtD
Propylthiouracil—Alopecia—Leflunomide—systemic scleroderma	0.00259	0.00328	CcSEcCtD
Propylthiouracil—Paraesthesia—Mometasone—systemic scleroderma	0.00258	0.00328	CcSEcCtD
Propylthiouracil—Vasculitis—Methotrexate—systemic scleroderma	0.00255	0.00323	CcSEcCtD
Propylthiouracil—Dyspepsia—Mometasone—systemic scleroderma	0.00253	0.00321	CcSEcCtD
Propylthiouracil—Hepatitis—Lisinopril—systemic scleroderma	0.00251	0.00319	CcSEcCtD
Propylthiouracil—Dysgeusia—Leflunomide—systemic scleroderma	0.00249	0.00317	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Captopril—systemic scleroderma	0.00247	0.00314	CcSEcCtD
Propylthiouracil—Alopecia—Mycophenolic acid—systemic scleroderma	0.00247	0.00313	CcSEcCtD
Propylthiouracil—Leukopenia—Azathioprine—systemic scleroderma	0.00241	0.00307	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Mycophenolate mofetil—systemic scleroderma	0.00241	0.00306	CcSEcCtD
Propylthiouracil—Jaundice—Mycophenolate mofetil—systemic scleroderma	0.00239	0.00304	CcSEcCtD
Propylthiouracil—Pruritus—Pentoxifylline—systemic scleroderma	0.00235	0.00299	CcSEcCtD
Propylthiouracil—Aplastic anaemia—Methotrexate—systemic scleroderma	0.00233	0.00296	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.0023	0.00292	CcSEcCtD
Propylthiouracil—Arthralgia—Azathioprine—systemic scleroderma	0.0023	0.00292	CcSEcCtD
Propylthiouracil—Myalgia—Azathioprine—systemic scleroderma	0.0023	0.00292	CcSEcCtD
Propylthiouracil—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.00229	0.00291	CcSEcCtD
Propylthiouracil—Vertigo—Leflunomide—systemic scleroderma	0.00229	0.00291	CcSEcCtD
Propylthiouracil—Leukopenia—Leflunomide—systemic scleroderma	0.00228	0.0029	CcSEcCtD
Propylthiouracil—Body temperature increased—Mometasone—systemic scleroderma	0.00227	0.00288	CcSEcCtD
Propylthiouracil—Paraesthesia—Captopril—systemic scleroderma	0.00227	0.00288	CcSEcCtD
Propylthiouracil—Somnolence—Captopril—systemic scleroderma	0.00224	0.00285	CcSEcCtD
Propylthiouracil—TPO—Hematopoietic Stem Cell Differentiation—IL1A—systemic scleroderma	0.00222	0.0765	CbGpPWpGaD
Propylthiouracil—Alopecia—Lisinopril—systemic scleroderma	0.00222	0.00282	CcSEcCtD
Propylthiouracil—Dyspepsia—Captopril—systemic scleroderma	0.00222	0.00282	CcSEcCtD
Propylthiouracil—Haemoglobin—Mycophenolate mofetil—systemic scleroderma	0.00221	0.00281	CcSEcCtD
Propylthiouracil—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.0022	0.0028	CcSEcCtD
Propylthiouracil—Haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.0022	0.0028	CcSEcCtD
Propylthiouracil—MPO—IL23-mediated signaling events—STAT4—systemic scleroderma	0.0022	0.0758	CbGpPWpGaD
Propylthiouracil—Vertigo—Mycophenolic acid—systemic scleroderma	0.00218	0.00277	CcSEcCtD
Propylthiouracil—Leukopenia—Mycophenolic acid—systemic scleroderma	0.00218	0.00276	CcSEcCtD
Propylthiouracil—Myalgia—Leflunomide—systemic scleroderma	0.00217	0.00275	CcSEcCtD
Propylthiouracil—Arthralgia—Leflunomide—systemic scleroderma	0.00217	0.00275	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00216	0.00274	CcSEcCtD
Propylthiouracil—Dysgeusia—Lisinopril—systemic scleroderma	0.00214	0.00272	CcSEcCtD
Propylthiouracil—Vomiting—Pentoxifylline—systemic scleroderma	0.00212	0.00269	CcSEcCtD
Propylthiouracil—Lymphadenopathy—Methotrexate—systemic scleroderma	0.00211	0.00269	CcSEcCtD
Propylthiouracil—Rash—Pentoxifylline—systemic scleroderma	0.0021	0.00267	CcSEcCtD
Propylthiouracil—Dermatitis—Pentoxifylline—systemic scleroderma	0.0021	0.00266	CcSEcCtD
Propylthiouracil—Headache—Pentoxifylline—systemic scleroderma	0.00209	0.00265	CcSEcCtD
Propylthiouracil—Arthralgia—Mycophenolic acid—systemic scleroderma	0.00207	0.00263	CcSEcCtD
Propylthiouracil—Myalgia—Mycophenolic acid—systemic scleroderma	0.00207	0.00263	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00204	0.00259	CcSEcCtD
Propylthiouracil—Pruritus—Mometasone—systemic scleroderma	0.00203	0.00258	CcSEcCtD
Propylthiouracil—Hepatic failure—Methotrexate—systemic scleroderma	0.00201	0.00255	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00201	0.00255	CcSEcCtD
Propylthiouracil—Body temperature increased—Captopril—systemic scleroderma	0.00199	0.00253	CcSEcCtD
Propylthiouracil—Oedema—Mycophenolic acid—systemic scleroderma	0.00198	0.00252	CcSEcCtD
Propylthiouracil—Nausea—Pentoxifylline—systemic scleroderma	0.00198	0.00251	CcSEcCtD
Propylthiouracil—Vertigo—Lisinopril—systemic scleroderma	0.00197	0.0025	CcSEcCtD
Propylthiouracil—Leukopenia—Lisinopril—systemic scleroderma	0.00196	0.00249	CcSEcCtD
Propylthiouracil—Renal failure acute—Methotrexate—systemic scleroderma	0.00195	0.00248	CcSEcCtD
Propylthiouracil—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.00195	0.00247	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00194	0.00247	CcSEcCtD
Propylthiouracil—Dermatitis exfoliative—Methotrexate—systemic scleroderma	0.00191	0.00243	CcSEcCtD
Propylthiouracil—MPO—Folate Metabolism—CSF1—systemic scleroderma	0.0019	0.0654	CbGpPWpGaD
Propylthiouracil—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.00189	0.00241	CcSEcCtD
Propylthiouracil—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.00188	0.00239	CcSEcCtD
Propylthiouracil—Paraesthesia—Leflunomide—systemic scleroderma	0.00187	0.00237	CcSEcCtD
Propylthiouracil—Arthralgia—Lisinopril—systemic scleroderma	0.00186	0.00237	CcSEcCtD
Propylthiouracil—Myalgia—Lisinopril—systemic scleroderma	0.00186	0.00237	CcSEcCtD
Propylthiouracil—Dyspepsia—Leflunomide—systemic scleroderma	0.00183	0.00232	CcSEcCtD
Propylthiouracil—Vomiting—Mometasone—systemic scleroderma	0.00183	0.00232	CcSEcCtD
Propylthiouracil—Rash—Mometasone—systemic scleroderma	0.00181	0.0023	CcSEcCtD
Propylthiouracil—Dermatitis—Mometasone—systemic scleroderma	0.00181	0.0023	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00181	0.00229	CcSEcCtD
Propylthiouracil—Headache—Mometasone—systemic scleroderma	0.0018	0.00229	CcSEcCtD
Propylthiouracil—Oedema—Lisinopril—systemic scleroderma	0.00179	0.00227	CcSEcCtD
Propylthiouracil—Pruritus—Captopril—systemic scleroderma	0.00178	0.00227	CcSEcCtD
Propylthiouracil—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00178	0.00226	CcSEcCtD
Propylthiouracil—Somnolence—Mycophenolic acid—systemic scleroderma	0.00176	0.00224	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00175	0.00222	CcSEcCtD
Propylthiouracil—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00175	0.00222	CcSEcCtD
Propylthiouracil—Body temperature increased—Azathioprine—systemic scleroderma	0.00174	0.00221	CcSEcCtD
Propylthiouracil—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00172	0.00219	CcSEcCtD
Propylthiouracil—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00172	0.00218	CcSEcCtD
Propylthiouracil—Nausea—Mometasone—systemic scleroderma	0.00171	0.00217	CcSEcCtD
Propylthiouracil—Urticaria—Leflunomide—systemic scleroderma	0.00165	0.0021	CcSEcCtD
Propylthiouracil—Body temperature increased—Leflunomide—systemic scleroderma	0.00164	0.00209	CcSEcCtD
Propylthiouracil—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.00163	0.00207	CcSEcCtD
Propylthiouracil—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.00163	0.00207	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Prednisone—systemic scleroderma	0.00163	0.00207	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00163	0.00207	CcSEcCtD
Propylthiouracil—Paraesthesia—Lisinopril—systemic scleroderma	0.0016	0.00204	CcSEcCtD
Propylthiouracil—Vomiting—Captopril—systemic scleroderma	0.0016	0.00204	CcSEcCtD
Propylthiouracil—Rash—Captopril—systemic scleroderma	0.00159	0.00202	CcSEcCtD
Propylthiouracil—Dermatitis—Captopril—systemic scleroderma	0.00159	0.00202	CcSEcCtD
Propylthiouracil—Somnolence—Lisinopril—systemic scleroderma	0.00159	0.00202	CcSEcCtD
Propylthiouracil—Headache—Captopril—systemic scleroderma	0.00158	0.00201	CcSEcCtD
Propylthiouracil—Dyspepsia—Lisinopril—systemic scleroderma	0.00157	0.002	CcSEcCtD
Propylthiouracil—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00157	0.00199	CcSEcCtD
Propylthiouracil—Oedema—Mycophenolate mofetil—systemic scleroderma	0.00157	0.00199	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00153	0.00195	CcSEcCtD
Propylthiouracil—Haemoglobin—Prednisone—systemic scleroderma	0.0015	0.00191	CcSEcCtD
Propylthiouracil—Nausea—Captopril—systemic scleroderma	0.0015	0.0019	CcSEcCtD
Propylthiouracil—Haemorrhage—Prednisone—systemic scleroderma	0.00149	0.0019	CcSEcCtD
Propylthiouracil—DBH—Monoamine Transport—IL1B—systemic scleroderma	0.00147	0.0507	CbGpPWpGaD
Propylthiouracil—Pruritus—Leflunomide—systemic scleroderma	0.00147	0.00187	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—COL1A2—systemic scleroderma	0.00143	0.0492	CbGpPWpGaD
Propylthiouracil—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00143	0.00181	CcSEcCtD
Propylthiouracil—Urticaria—Lisinopril—systemic scleroderma	0.00142	0.0018	CcSEcCtD
Propylthiouracil—DIO1—Selenium Micronutrient Network—CCL2—systemic scleroderma	0.00142	0.0488	CbGpPWpGaD
Propylthiouracil—Body temperature increased—Lisinopril—systemic scleroderma	0.00141	0.00179	CcSEcCtD
Propylthiouracil—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00141	0.00179	CcSEcCtD
Propylthiouracil—Pruritus—Mycophenolic acid—systemic scleroderma	0.0014	0.00178	CcSEcCtD
Propylthiouracil—Vomiting—Azathioprine—systemic scleroderma	0.0014	0.00178	CcSEcCtD
Propylthiouracil—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00139	0.00177	CcSEcCtD
Propylthiouracil—Drowsiness—Methotrexate—systemic scleroderma	0.00139	0.00177	CcSEcCtD
Propylthiouracil—Rash—Azathioprine—systemic scleroderma	0.00139	0.00176	CcSEcCtD
Propylthiouracil—Dermatitis—Azathioprine—systemic scleroderma	0.00139	0.00176	CcSEcCtD
Propylthiouracil—Headache—Azathioprine—systemic scleroderma	0.00138	0.00175	CcSEcCtD
Propylthiouracil—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00138	0.00175	CcSEcCtD
Propylthiouracil—Vomiting—Leflunomide—systemic scleroderma	0.00132	0.00168	CcSEcCtD
Propylthiouracil—Alopecia—Prednisone—systemic scleroderma	0.00132	0.00168	CcSEcCtD
Propylthiouracil—Rash—Leflunomide—systemic scleroderma	0.00131	0.00166	CcSEcCtD
Propylthiouracil—Dermatitis—Leflunomide—systemic scleroderma	0.00131	0.00166	CcSEcCtD
Propylthiouracil—Nausea—Azathioprine—systemic scleroderma	0.00131	0.00166	CcSEcCtD
Propylthiouracil—Headache—Leflunomide—systemic scleroderma	0.0013	0.00165	CcSEcCtD
Propylthiouracil—Agranulocytosis—Methotrexate—systemic scleroderma	0.0013	0.00165	CcSEcCtD
Propylthiouracil—Pruritus—Lisinopril—systemic scleroderma	0.00126	0.00161	CcSEcCtD
Propylthiouracil—Vomiting—Mycophenolic acid—systemic scleroderma	0.00126	0.0016	CcSEcCtD
Propylthiouracil—Haemoglobin—Methotrexate—systemic scleroderma	0.00125	0.00159	CcSEcCtD
Propylthiouracil—Rash—Mycophenolic acid—systemic scleroderma	0.00125	0.00159	CcSEcCtD
Propylthiouracil—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00125	0.00159	CcSEcCtD
Propylthiouracil—Hepatitis—Methotrexate—systemic scleroderma	0.00125	0.00159	CcSEcCtD
Propylthiouracil—Haemorrhage—Methotrexate—systemic scleroderma	0.00125	0.00159	CcSEcCtD
Propylthiouracil—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00124	0.00158	CcSEcCtD
Propylthiouracil—Headache—Mycophenolic acid—systemic scleroderma	0.00124	0.00158	CcSEcCtD
Propylthiouracil—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00124	0.00157	CcSEcCtD
Propylthiouracil—Nausea—Leflunomide—systemic scleroderma	0.00123	0.00157	CcSEcCtD
Propylthiouracil—Nausea—Mycophenolic acid—systemic scleroderma	0.00118	0.0015	CcSEcCtD
Propylthiouracil—Vertigo—Prednisone—systemic scleroderma	0.00117	0.00148	CcSEcCtD
Propylthiouracil—TPO—Hematopoietic Stem Cell Differentiation—IL1B—systemic scleroderma	0.00116	0.0399	CbGpPWpGaD
Propylthiouracil—Vomiting—Lisinopril—systemic scleroderma	0.00114	0.00144	CcSEcCtD
Propylthiouracil—Rash—Lisinopril—systemic scleroderma	0.00113	0.00143	CcSEcCtD
Propylthiouracil—Dermatitis—Lisinopril—systemic scleroderma	0.00113	0.00143	CcSEcCtD
Propylthiouracil—Headache—Lisinopril—systemic scleroderma	0.00112	0.00142	CcSEcCtD
Propylthiouracil—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00111	0.00141	CcSEcCtD
Propylthiouracil—Arthralgia—Prednisone—systemic scleroderma	0.00111	0.00141	CcSEcCtD
Propylthiouracil—Myalgia—Prednisone—systemic scleroderma	0.00111	0.00141	CcSEcCtD
Propylthiouracil—Alopecia—Methotrexate—systemic scleroderma	0.0011	0.0014	CcSEcCtD
Propylthiouracil—DIO1—Selenium Micronutrient Network—IL1B—systemic scleroderma	0.00107	0.037	CbGpPWpGaD
Propylthiouracil—Dysgeusia—Methotrexate—systemic scleroderma	0.00106	0.00135	CcSEcCtD
Propylthiouracil—Nausea—Lisinopril—systemic scleroderma	0.00106	0.00135	CcSEcCtD
Propylthiouracil—Oedema—Prednisone—systemic scleroderma	0.00106	0.00135	CcSEcCtD
Propylthiouracil—MPO—IL23-mediated signaling events—CCL2—systemic scleroderma	0.00102	0.0351	CbGpPWpGaD
Propylthiouracil—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000995	0.00126	CcSEcCtD
Propylthiouracil—Rash—Mycophenolate mofetil—systemic scleroderma	0.000987	0.00125	CcSEcCtD
Propylthiouracil—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000986	0.00125	CcSEcCtD
Propylthiouracil—Headache—Mycophenolate mofetil—systemic scleroderma	0.000981	0.00125	CcSEcCtD
Propylthiouracil—Vertigo—Methotrexate—systemic scleroderma	0.000976	0.00124	CcSEcCtD
Propylthiouracil—Leukopenia—Methotrexate—systemic scleroderma	0.000973	0.00124	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000967	0.00123	CcSEcCtD
Propylthiouracil—Paraesthesia—Prednisone—systemic scleroderma	0.000953	0.00121	CcSEcCtD
Propylthiouracil—Dyspepsia—Prednisone—systemic scleroderma	0.000934	0.00119	CcSEcCtD
Propylthiouracil—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00093	0.00118	CcSEcCtD
Propylthiouracil—Arthralgia—Methotrexate—systemic scleroderma	0.000925	0.00117	CcSEcCtD
Propylthiouracil—Myalgia—Methotrexate—systemic scleroderma	0.000925	0.00117	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000868	0.0011	CcSEcCtD
Propylthiouracil—Urticaria—Prednisone—systemic scleroderma	0.000843	0.00107	CcSEcCtD
Propylthiouracil—Body temperature increased—Prednisone—systemic scleroderma	0.000839	0.00107	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000808	0.00103	CcSEcCtD
Propylthiouracil—Paraesthesia—Methotrexate—systemic scleroderma	0.000796	0.00101	CcSEcCtD
Propylthiouracil—MPO—Vitamin B12 Metabolism—CCL2—systemic scleroderma	0.000789	0.0272	CbGpPWpGaD
Propylthiouracil—Somnolence—Methotrexate—systemic scleroderma	0.000788	0.001	CcSEcCtD
Propylthiouracil—Dyspepsia—Methotrexate—systemic scleroderma	0.000781	0.000991	CcSEcCtD
Propylthiouracil—TPO—Differentiation Pathway—TGFB1—systemic scleroderma	0.000778	0.0268	CbGpPWpGaD
Propylthiouracil—MPO—IL23-mediated signaling events—IL1B—systemic scleroderma	0.000773	0.0266	CbGpPWpGaD
Propylthiouracil—Pruritus—Prednisone—systemic scleroderma	0.000751	0.000953	CcSEcCtD
Propylthiouracil—Urticaria—Methotrexate—systemic scleroderma	0.000704	0.000895	CcSEcCtD
Propylthiouracil—Body temperature increased—Methotrexate—systemic scleroderma	0.000701	0.00089	CcSEcCtD
Propylthiouracil—Vomiting—Prednisone—systemic scleroderma	0.000675	0.000857	CcSEcCtD
Propylthiouracil—Rash—Prednisone—systemic scleroderma	0.000669	0.00085	CcSEcCtD
Propylthiouracil—Dermatitis—Prednisone—systemic scleroderma	0.000668	0.000849	CcSEcCtD
Propylthiouracil—Headache—Prednisone—systemic scleroderma	0.000665	0.000844	CcSEcCtD
Propylthiouracil—MPO—Folate Metabolism—CCL2—systemic scleroderma	0.000642	0.0221	CbGpPWpGaD
Propylthiouracil—Nausea—Prednisone—systemic scleroderma	0.00063	0.0008	CcSEcCtD
Propylthiouracil—Pruritus—Methotrexate—systemic scleroderma	0.000627	0.000797	CcSEcCtD
Propylthiouracil—MPO—Vitamin B12 Metabolism—IL1B—systemic scleroderma	0.000598	0.0206	CbGpPWpGaD
Propylthiouracil—Vomiting—Methotrexate—systemic scleroderma	0.000564	0.000716	CcSEcCtD
Propylthiouracil—Rash—Methotrexate—systemic scleroderma	0.000559	0.00071	CcSEcCtD
Propylthiouracil—Dermatitis—Methotrexate—systemic scleroderma	0.000559	0.000709	CcSEcCtD
Propylthiouracil—Headache—Methotrexate—systemic scleroderma	0.000556	0.000705	CcSEcCtD
Propylthiouracil—Nausea—Methotrexate—systemic scleroderma	0.000527	0.000669	CcSEcCtD
Propylthiouracil—MPO—Selenium Micronutrient Network—CCL2—systemic scleroderma	0.00051	0.0176	CbGpPWpGaD
Propylthiouracil—MPO—Folate Metabolism—IL1B—systemic scleroderma	0.000487	0.0168	CbGpPWpGaD
Propylthiouracil—MPO—Selenium Micronutrient Network—IL1B—systemic scleroderma	0.000387	0.0133	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—HSPG2—systemic scleroderma	0.000383	0.0132	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—CTGF—systemic scleroderma	0.00029	0.00999	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—HSPG2—systemic scleroderma	0.000234	0.00805	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—HSPG2—systemic scleroderma	0.00022	0.00757	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CTGF—systemic scleroderma	0.000177	0.0061	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CTGF—systemic scleroderma	0.000167	0.00574	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—NOS3—systemic scleroderma	0.000126	0.00435	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—NOS3—systemic scleroderma	7.71e-05	0.00266	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—NOS3—systemic scleroderma	7.25e-05	0.0025	CbGpPWpGaD
